Les troubles neurocognitifs post-AVC légers et majeurs : du diagnostic à la prise en charge

Aevarsson, 1998, Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia, Arch Neurol, 55, 1226, 10.1001/archneur.55.9.1226 Saposnik, 2011, Registry of the Canadian Stroke Network; Stroke Outcome Research Canada (SORCan) working group. Care and outcomes in patients with ischemic stroke with and without preexisting dementia, Neurology, 77, 1664, 10.1212/WNL.0b013e31823648f1 Tatemichi, 1994, Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities, J Neurol Neurosurg Psychiatry, 57, 202, 10.1136/jnnp.57.2.202 Rockwood, 2000, Prevalence and outcomes of vascular cognitive impairment. Vascular cognitive impairment investigators of the canadian study of health and aging, Neurology, 54, 447, 10.1212/WNL.54.2.447 Moroney, 1997, Dementia after stroke increases the risk of long-term stroke recurrence, Neurology, 48, 1317, 10.1212/WNL.48.5.1317 Lee, 2014, Cognitive impairment and risk of future stroke: a systematic review and meta-analysis, CMAJ, 186, 10.1503/cmaj.140147 Goudefroy, 2013, Vascular cognitive impairment in the stroke unit and after the acute stage, 22 Hackett, 2014, Part I: Frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies, Int J Stroke, 9, 1017, 10.1111/ijs.12357 Morris, 1993, Association of depression with 10-year poststroke mortality, Am J Psychiatry, 150, 124, 10.1176/ajp.150.1.124 Kutlubaev, 2014, Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies, Int J Stroke, 9, 1026, 10.1111/ijs.12356 Leys, 2005, Poststroke dementia, Lancet Neurol, 4, 752, 10.1016/S1474-4422(05)70221-0 Pendlebury, 2009, Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis, Lancet Neurol, 8, 1006, 10.1016/S1474-4422(09)70236-4 Barbay M, Diouf M, Roussel M, Godefroy O, Grecogvasc study group. Prevalence of post-stroke neurocognitive disorders in hospital-based studies: a systematic review and meta-analysis. Soumis. Barbay M, Taillia H, Nédélec-Ciceri C, Bompaire F, Bonnin, Varvat J, et al. Prevalence of post-stroke neurocognitive disorders using NINDS-CSN, VASCOG criteria and optimized criteria of cognitive deficit. In revision Pendlebury, 2015, Oxford vascular study. Methodological factors in determining risk of dementia after transient ischemic attack and stroke: (III) applicability of cognitive tests, Stroke, 46, 3067, 10.1161/STROKEAHA.115.010290 Hénon, 1997, Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome, Stroke, 28, 2429, 10.1161/01.STR.28.12.2429 Cordonnier, 2010, What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?, Brain, 133, 3281, 10.1093/brain/awq246 Garcia, 2013, Cognitive impairment and dementia following intracerebral hemorrhage: a cross-sectional study of a university hospital-based series, J Stroke Cerebrovasc Dis, 22, 80, 10.1016/j.jstrokecerebrovasdis.2011.06.013 Roussel, 2016, The behavioral and cognitive executive disorders of stroke, PLoS One, 11, 10.1371/journal.pone.0147602 Moulin, 2016, Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study, Lancet Neurol, 15, 820, 10.1016/S1474-4422(16)00130-7 Bugnicourt, 2013, Cognitive impairment after cerebral venous thrombosis: a two-center study, J Neurol, 260, 1324, 10.1007/s00415-012-6799-5 Qiu, 2005, The age-dependent relation of blood pressure to cognitive function and dementia, Lancet Neurol, 4, 487, 10.1016/S1474-4422(05)70141-1 Debette, 2011, Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline, Neurology, 77, 461, 10.1212/WNL.0b013e318227b227 Gottesman, 2017, Association between midlife vascular risk factors and estimated brain amyloid deposition, JAMA, 317, 1443, 10.1001/jama.2017.3090 Vermeer, 2003, Silent brain infarcts and the risk of dementia and cognitive decline, N Engl J Med, 348, 1215, 10.1056/NEJMoa022066 Tatemichi, 1990, Dementia in stroke survivors in the Stroke Data Bank cohort: prevalence, incidence, risk factors, and computed tomographic findings, Stroke, 21, 858, 10.1161/01.STR.21.6.858 Mok, 2010, Pittsburgh compound B binding in poststroke dementia, J Neurol Sci, 290, 135, 10.1016/j.jns.2009.12.014 Picard, 2011, Early onset dementia: characteristics in a large cohort from academic memory clinics, Alzheimer Dis Assoc Disord, 25, 203, 10.1097/WAD.0b013e3182056be7 Godefroy, 2011, Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect post-stroke cognitive impairment? A study with neuropsychological evaluation, Stroke, 42, 1712, 10.1161/STROKEAHA.110.606277 Lees, 2014, Test accuracy of cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke, Stroke, 45, 3008, 10.1161/STROKEAHA.114.005842 Roussel, 2016, Évaluation des troubles cognitifs et comportementaux d’origine vasculaire: la batterie GRECOGVASC, 205 Godefroy, 2012, The Rankin scale with revised structured interview: effect on reliability, grading of disability and detection of dementia, Int J Stroke, 7, 183, 10.1111/j.1747-4949.2011.00743.x Hachinski, 2006, National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards, Stroke, 37, 2220, 10.1161/01.STR.0000237236.88823.47 Sachdev, 2014, Internationlal society for vascular behavioral and cognitive disorders. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement, Alzheimer Dis Assoc Disord, 28, 206, 10.1097/WAD.0000000000000034 Forette, 1998, Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial, Lancet, 352, 1347, 10.1016/S0140-6736(98)03086-4 McGuinness, 2009, Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia, Cochrane Database Syst Rev Anderson, 2011, ONTARGET and TRANSCEND Investigator. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies, Lancet Neurol, 10, 43, 10.1016/S1474-4422(10)70250-7 Fournier, 2009, Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors, Expert Rev Neurother, 9, 1413, 10.1586/ern.09.89 Yasar, 2016, Relationship between antihypertensive medications and cognitive impairment: part I. Review of human studies and clinical trials, Curr Hypertens Rep, 18, 67, 10.1007/s11906-016-0674-1 Tzourio, 2003, PROGRESS collaborative group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease, Arch Intern Med, 163, 1069, 10.1001/archinte.163.9.1069 Diener, 2008, Lancet Neurol, 7, 875, 10.1016/S1474-4422(08)70198-4 Pearce, 2014, SPS3 investigators. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial, Lancet Neurol, 13, 1177, 10.1016/S1474-4422(14)70224-8 Biessels, 2006, Risk of dementia in diabetes mellitus: a systematic review, Lancet Neurol, 5, 64, 10.1016/S1474-4422(05)70284-2 Areosa Sastre, 2017, Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia, Cochrane Database Syst Rev, 6 Yaffe, 2013, Health ABC study. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus, JAMA Intern Med, 173, 1300, 10.1001/jamainternmed.2013.6176 Matz, 2015, ASPIS study group. Multidomain lifestyle interventions for the prevention of cognitive decline after ischemic stroke: randomized trial, Stroke, 46, 2874, 10.1161/STROKEAHA.115.009992 Ngandu, 2015, A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial, Lancet, 385, 2255, 10.1016/S0140-6736(15)60461-5 Tang, 2016, High- and low-intensity exercise do not improve cognitive function after stroke: a randomized controlled trial, J Rehabil Med, 48, 841, 10.2340/16501977-2163 Hankey, 2013, VITATOPS trial study group. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis, Stroke, 44, 2232, 10.1161/STROKEAHA.113.001886 Crijnen, 2016, MR CLEAN investigators. Early effect of intra-arterial treatment in ischemic stroke on aphasia recovery in MR CLEAN, Neurology, 86, 2049, 10.1212/WNL.0000000000002724 López-Cancio, 2017, Endovascular treatment improves cognition after stroke: a secondary analysis of REVASCAT trial, Neurology, 88, 245, 10.1212/WNL.0000000000003517 De Rango, 2008, The role of carotid artery stenting and carotid endarterectomy in cognitive performance: a systematic review, Stroke, 39, 3116, 10.1161/STROKEAHA.108.518357 Paraskevas, 2014, Comparison of cognitive function after carotid artery stenting versus carotid endarterectomy, Eur J Vasc Endovasc Surg, 47, 221, 10.1016/j.ejvs.2013.11.006 Marshall, 2014, RECON investigators. Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results, Neurology, 82, 744, 10.1212/WNL.0000000000000167 Turan, 2017, SAMMPRIS investigators. Is there benefit from stenting on cognitive function in intracranial atherosclerosis?, Cerebrovasc Dis, 43, 31, 10.1159/000450964 Scott, 2010, Improved cognitive outcomes with endovascular coiling of ruptured intracranial aneurysms: neuropsychological outcomes from the International Subarachnoid Aneurysm Trial (ISAT), Stroke, 41, 1743, 10.1161/STROKEAHA.110.585240 Moultrie, 2014, Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators. Outcome after surgical or conservative management of cerebral cavernous malformations, Neurology, 83, 582, 10.1212/WNL.0000000000000684 Mohr, 2014, International ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial, Lancet, 383, 614, 10.1016/S0140-6736(13)62302-8 Meinzer, 2016, Electrical stimulation of the motor cortex enhances treatment outcome in post-stroke aphasia, Brain, 139, 1152, 10.1093/brain/aww002 Walker-Batson, 2001, A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia, Stroke, 32, 2093, 10.1161/hs0901.095720 Jorge, 2010, Escitalopram and enhancement of cognitive recovery following stroke, Arch Gen Psychiatry, 67, 187, 10.1001/archgenpsychiatry.2009.185 Chollet, 2011, Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial, Lancet Neurol, 10, 123, 10.1016/S1474-4422(10)70314-8 Hackett, 2013, Depression after stroke and cerebrovascular disease, 363 Hackett, 2008, Interventions for treating depression after stroke, Cochrane Database Syst Rev Towfighi, 2017, Stroke, 48, 10.1161/STR.0000000000000113 Legg, 2007, Occupational therapy for patients with problems in personal activities of daily living after stroke: systematic review of randomised trials, BMJ, 335, 922, 10.1136/bmj.39343.466863.55 Sackley, 2015, OTCH trial investigators. An occupational therapy intervention for residents with stroke related disabilities in UK carehomes (OTCH): cluster randomised controlled trial, BMJ, 350, 10.1136/bmj.h468 Narasimhalu, 2010, A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease, Acta Neurol Scand, 121, 217, 10.1111/j.1600-0404.2009.01263.x Kavirajan, 2007, Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials, Lancet Neurol, 6, 782, 10.1016/S1474-4422(07)70195-3 Dichgans, 2008, Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL, Lancet Neurol, 7, 310, 10.1016/S1474-4422(08)70046-2 Muresanu, 2016, Cerebrolysin and Recovery After Stroke (CARS): a randomized, placebo-controlled, double-blind, multicenter trial, Stroke, 47, 151, 10.1161/STROKEAHA.115.009416 Guekht, 2017, ARTEMIDA Trial (A randomized trial of efficacy, 12 months international double-blind actovegin): a randomized controlled trial to assess the efficacy of actovegin in poststroke cognitive impairment, Stroke, 48, 1262, 10.1161/STROKEAHA.116.014321